Misonix Has Been Acquired by Bioventus
On October 29, 2021, Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced the acquisition of Misonix, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. The current Misonix product offerings are state-of-the-art technologies that are supported by next generation products in the pipeline and this agreement will allow those to scale and reach their full potential.
To learn more about Misonix and Misonix’s product offerings, click on one of the links below.
Interested in Misonix careers. Click here for current job postings.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for pain treatment, restorative therapies and surgical solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter.
